Corporate, financial, product, speech & presentation, press release - You name it!

Live Webinar on Immunoscore®

Don't miss Jérôme Galon presentation on "Identification of good prognostic ColonCancer stage II patients for whom adjuvant treatment may be avoided" during the Live Webinar on March 21, 2019 !

Jérôme Galon will share a new sub-analysis of the SITC multicentric study recently presented in an International GI congress.

You will learn how Immunoscore® brings new information in stage II patients having clinicopathological  high-risk features by identifying a subgroup with good prognosis for  whom adjuvant therapy may be avoided.

We propose two live sessions to fit your schedule : March 21, 2019 11:30 AM CET and 5:30 PM CET

Select the desired session in the drop-down menu on the registration page here.